What is Vera Therapeutics's share buybacks?

Vera Therapeutics (VERA) reported share buybacks of $0 in Q4 2025.

How has Vera Therapeutics's share buybacks changed year-over-year?

Vera Therapeutics's share buybacks decreased by 100.0% year-over-year, from $3.25K to $0.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Vera Therapeutics VERA Share Buybacks

Share Buybacks at other companies

Vertex PharmaceuticalsVRTX

$336.9M-20.9%

Aurinia PharmaceuticalsAUPH

$36.17M-22.9%

Johnson & JohnsonJNJ

$4.03B+89.4%

Merck & Co.MRK

$874M-24.9%

TG TherapeuticsTGTX

$99.99M+1,533%

AbbVieABBV

$1.49B+54.9%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.84B+87.5%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Vera Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's share buybacks?: Vera Therapeutics (VERA) reported share buybacks of $0 in Q4 2025.
How has Vera Therapeutics's share buybacks changed year-over-year?: Vera Therapeutics's share buybacks decreased by 100.0% year-over-year, from $3.25K to $0.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.